glp-1 and type 2 diabetes GLP-1-based therapies for diabetes: from single, dual triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 receptor agonists are increasingly

Last reviewed: June 28, 2026 Last updated: June 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

These meds suppress appetiteif you dont get enough protein, your body may burn muscle

Significant joint pain, persistent numbness or tingling, or notable changes in blood glucose warrant reassessment

Additionally, while there are no known toxic effects from expired semaglutide, using degraded medications can sometimes lead to increased risks due to contamination or breakdown of chemical components

The 24-year-old used to sleep 12 hours, wake up listless at noon and rely on DoorDash for most meals